Hematopoietic Stem Cell Transplantation clinical trials

Explore recruiting hematopoietic stem cell transplantation clinical trials.

Recruiting hematopoietic stem cell transplantation studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hematopoietic Stem Cell Transplantation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A multicenter randomized trial of fosfomycin versus ciprofloxacin for febrile neutropenia in hematologic patients: efficacy and microbiologic safety.

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

DK-CLIC-1901 CAR T-cells for treatment of patients with relapsed/refractory CD19 positive hematological malignancies (DAN-CART 1901)

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

A Multicenter, Open-Label, Dose-Finding Clinical Trial to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of RVU120 in Combination with Venetoclax in Participants with Acute Myeloid Leukemia Who Failed Prior Therapy with Venetoclax and a Hypomethylating Agent (RIVER-81)

Italy, Poland, France, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Magrolimab plus intensive chemotherapy in newly diagnosed “ELN intermediate or poor-risk” AML patients intended to undergo allogeneic stem cell transplantation, a Phase 2, Single-arm, Open-Label Study (MAGROLIC)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Semaglutide Treatment for Prevention of Toxicity in High-dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation – a randomized, double-blind, placebo-controlled, investigator-initiated study

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Comparison of esketamine mouthwash versus intravenous administration for the treatment of chemotherapy/radiotherapy-induced mucositis

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Hematopoietic Stem Cell Transplantation trials by city

Hematopoietic Stem Cell Transplantation in Toronto Hematopoietic Stem Cell Transplantation in Vancouver Hematopoietic Stem Cell Transplantation in Montreal Hematopoietic Stem Cell Transplantation in Calgary Hematopoietic Stem Cell Transplantation in Edmonton Hematopoietic Stem Cell Transplantation in Ottawa Hematopoietic Stem Cell Transplantation in Winnipeg Hematopoietic Stem Cell Transplantation in Quebec City Hematopoietic Stem Cell Transplantation in Hamilton Hematopoietic Stem Cell Transplantation in Kitchener Hematopoietic Stem Cell Transplantation in London Hematopoietic Stem Cell Transplantation in Halifax Hematopoietic Stem Cell Transplantation in New York Hematopoietic Stem Cell Transplantation in Los Angeles Hematopoietic Stem Cell Transplantation in Chicago Hematopoietic Stem Cell Transplantation in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease